On February 6, 2023 Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, reported that its management team will participate at the following investor conferences (Press release, Personalis, FEB 6, 2023, View Source [SID1234626900]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Participating on Thursday, February 16, 2023 at The Cliff Lodge in Snowbird, UT
43rd Annual Cowen Healthcare Conference
Presenting on Tuesday, March 7, 2023 at 10:30 a.m. Eastern Time at the Boston Marriott Copley Place in Boston, MA